Multi-omic profiling sheds light on chemo-immunotherapy resistance in lung cancer

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and potential therapeutic strategies.

ECRI Unveils Top 10 Health Technology Hazards for 2024

What You Should Know: – ECRI, an independent healthcare safety organization, has released its annual Top 10 Health Technology Hazards list for 2024, highlighting critical

February 1, 2024

Highly-awaited PhIII study of Gates-backed tuberculosis vaccine underway

A large study of an experimental vaccine for the world’s biggest infectious disease has finally kicked off in South Africa. The Bill & Melinda Gates

March 20, 2024

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

Research shows prenatal exposure to SARS-CoV-2 linked to slight regulatory behavior improvements in infants, but no significant neurodevelopmental impacts.

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.